News
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...
Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...
The federal government's Medicare program and older adults together spend $4.4 billion a year on care that has low clinical ...
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...
Working seniors need professional advice when making coverage decisions, but only 21% of retirees with advisers receive ...
Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...
A new study finds Medicare pays billions annually for low-value tests and treatments. See which procedures waste the most and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results